Brief: Kala Pharmaceuticals Q1 EPS USD -4.2

KALA BIO

14/05/2024 21:05

May 14 (Reuters) - Kala Pharmaceuticals Q1 net income USD -11.807 million.
* Q1 income from operations USD -11.931 million
* Q1 operating expenses USD 11.931 million